Why BKYI Stock dropped -6.69% Today — RQD Quant Desk Flash
BIO-key International Inc. (BKYI) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
FRED Regime × Technicals: 11% of 52W Range • RSI-14 at 51.1 (NEUTRAL RANGE)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
⚔️ Adversarial Opposing Case: What Could Spark a BKYI Turnaround Squeeze
While BKYI currently carries a cautious 33/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.58) and Max Pain ($3.08) forces dealer call-delta covering toward $14.49.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why BKYI Stock dropped -6.69% Today — RQD Quant Desk Flash
BIO-key International Inc. (BKYI) dropped -6.69% to $2.93, trading at 11% of its 52-week range ($1.55 – $13.8). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 11% of its 52-week range ($1.55 – $13.8) with RSI-14 at 51.1 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.93 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 76.9% gross margin and $0 annual free cash flow.
Gainers PicoCELA (NASDAQ:PCLA) stock moved upwards by 34.6% to $7.9 during Thursday's pre-market session. The market value of their outstanding shares is at $56.4 million. Cohu (NASDAQ:COHU) stock moved upwards by
Gainers Impinj (NASDAQ:PI) stock moved upwards by 7.1% to $189.0 during Wednesday's after-market session. The company's market cap stands at $5.3 billion. As per the press release, Q3 earnings came out today.
BIO-key International, Inc. (NASDAQ:BKYI) has deployed its identity and access management technology to an additional customer within a Middle Eastern government’s national security network, expanding its involvement in
US-listed premarket movers for Oct. 28, 2026, led by AUROW, BRAI, ELPW, RCT and AXGN among gainers, while SCKT, AXG, NEXR and GRMLW fell.
Gainers Datavault AI (NASDAQ:DVLT) shares moved upwards by 24.6% to $0.08 during Wednesday's regular session. The market value of their outstanding shares is at $57.2 million. AIB Data Centers (AMEX:AIB) shares
Hayward Holdings (HAYW) delivered earnings and revenue surprises of +20.00% and +3.23%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Gainers Braiin (NASDAQ:BRAI) shares increased by 26.9% to $4.2 during Wednesday's pre-market session. The company's market cap stands at $682.1 million. Ultra Clean Hldgs (NASDAQ:UCTT) stock increased by
RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentication solutions, toda
Gainers Amplitech Group, Inc. - Series B Right (NASDAQ:AMPGZ) shares rose 50.3% to $0.05 during Monday's regular session. ClearOne (NASDAQ:CLRO) shares moved upwards by 46.15% to $4.75. The company's market
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BKYI)
- ✓Walkthrough of BKYI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
BKYI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BKYI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BKYI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BKYI)
1. Head-to-Head Technology Peer Comparison (BKYI vs. IFBD, ORKT, GYGY, LHSW)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, BIO-key International Inc. (BKYI) ranks #646 by composite RQD confidence (33/100, grade E) and #666 by equity capitalization ($6.0M). Within this direct 5-issuer industry benchmark cohort, BKYI leads on earnings valuation at N/A trailing P/E, while BKYI leads on capital efficiency and profitability with -35.0% ROIC and 76.9% gross margin. LHSW currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with BKYI at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BKYI
ACTIVE
BIO-key International Inc. | E | 33/100 | — | 76.9% | -35.0% | -6.69% | $6.0M | Benchmark Subject |
| IFBD Infobird Co. Ltd | D- | 38/100 | — | 29.5% | -35.0% | -7.94% | $6.1M | /ifbd-vs-bkyi → |
| ORKT Orangekloud Technology Inc. (Class A) | E | 30/100 | — | 44.2% | -35.0% | -0.99% | $5.8M | /orkt-vs-bkyi → |
| GYGY Game Your Game Inc. | D- | 35/100 | — | 8.6% | -35.0% | +7.59% | $5.7M | /gygy-vs-bkyi → |
| LHSW Lianhe Sowell International Group Ltd (Class A) | D | 48/100 | — | 21.4% | — | +9.55% | $6.6M | /lhsw-vs-bkyi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001019034In its most recent audited fiscal period (FY2025, filed 2025-12-31), BIO-key International Inc. (BKYI) reported GAAP revenue of $5.9M (-14.3% vs. FY2024 revenue of $6.9M ) , GAAP net income of $7.2M, operating cash flow of -$4.7M, and free cash flow of -$4.7M (-59.9% YoY). On the balance sheet, BKYI closed FY2025 with $8.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $5.9M | $7.2M | -$4.7M | -$4.7M | $8.3M | — |
| FY2024 (FY) | 2024-12-31 | $6.9M | $4.3M | -$2.9M | -$2.9M | $8.6M | $44.8K |
| FY2023 (FY) | 2023-12-31 | $0 | $8.5M | -$3.8M | -$3.8M | — | — |
3. BKYI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, BIO-key International Inc. (NASDAQ: BKYI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.93 (-6.69% 1D, market cap $6.0M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 714 tracked Technology issuers, BKYI ranks #646 in composite RQD confidence.
How does BKYI compare to IFBD and ORKT in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, IFBD (Infobird Co. Ltd) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $6.1M) and ORKT (Orangekloud Technology Inc. (Class A)) posts a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BKYI?
Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BKYI trading relative to its 50-day, 200-day, and 52-week technical levels?
BKYI last traded at $2.93 (-6.69% on volume of 575,103 shares), positioning the stock +13.57% above its 50-day simple moving average ($2.58) and -35.75% below its 200-day simple moving average ($4.56). Across its 52-week range of $1.55 to $13.80, BKYI sits at the 11.3% percentile with a 14-day RSI of 51.1 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.56 to $3.30).
BKYI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BKYI stock moving today?
Why BKYI Stock dropped -6.69% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.